首页 | 本学科首页   官方微博 | 高级检索  
     

不同电荷肿瘤乏氧显像剂的合成及生物分布
引用本文:黄士堂,王祥云,褚泰伟.不同电荷肿瘤乏氧显像剂的合成及生物分布[J].核化学与放射化学,2012,34(1):27-33.
作者姓名:黄士堂  王祥云  褚泰伟
作者单位:北京大学化学与分子工程学院放射化学与辐射化学重点学科实验室北京分子科学国家实验室
基金项目:国家自然科学基金资助项目(20771011,21071010,91026011)
摘    要:电荷是药物分子的重要性质,可以影响其在体内的生物学行为。为了研究不同电性质的肿瘤乏氧显像剂在体内的生物分布行为,合成了3种带有不同电荷的肿瘤乏氧显像剂(S)-3-(4-羟基苯基)-2-(3-(2-硝基咪唑基)丙酰胺基)丙酸甲酯(NI-Y-M)、(S)-3-(4-羟基苯基)-2-(3-(2-硝基咪唑基)丙酰胺基)丙酸(NI-Y)和(S)-N-(3-胺丙基)-3-(4-羟基苯基)-2-(3-(2-硝基咪唑基)丙酰胺基)丙酰胺(NI-Y-A),并进行了131I标记。3种化合物的标记率均大于95%,体外稳定性好。纸上电泳结果表明,在生理条件下,131I]NI-Y-M为中性分子,131I]NI-Y和131I]NI-Y-A则分别呈现负电和正电的电性质。从荷S180肉瘤小鼠体内分布结果发现:3种标记物在肿瘤组织呈现出快摄取慢清除的趋势,并且在肿瘤中的放射性活度明显高于肌肉和心、脑、脾等组织;随着时间的延长,肿瘤的相对摄取率提高;4h时,动物肿瘤与肌肉、肿瘤与血液放射性摄取的比值数据显示,带正电荷的标记物131I]NI-Y-A是最优的肿瘤乏氧显像剂。

关 键 词:乏氧显像剂  2-硝基咪唑  131I标记  电荷  生物分布

Preparation and Biodistribution of Tumor Hypoxia Imaging Agents With Different Charges
HUANG Shi-tang,WANG Xiang-yun,CHU Tai-wei.Preparation and Biodistribution of Tumor Hypoxia Imaging Agents With Different Charges[J].Journal of Nuclear and Radiochemistry,2012,34(1):27-33.
Authors:HUANG Shi-tang  WANG Xiang-yun  CHU Tai-wei
Affiliation:Beijing National Laboratory for Molecular Sciences,Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science,College of Chemistry and Molecular Engineering,Peking University,Beijing 100871,China
Abstract:The charge is an important characteristic of a drug molecule.The overall charge on a drug affects its pharmacological properties in vivo.In this study,(S)-methyl 3-(4-hydroxyphenyl)-2-(3-(2-nitro-1H-imidazol-1-yl)propanamido)propanoate(NI-Y-M),(S)-3-(4-hydroxyphenyl)-2-(3-(2-nitro-1H-imidazol-1-yl)propanamido) propanoic acid(NI-Y) and(S)-N-(3-aminopropyl)-3-(4-hydroxyphenyl)-2-(3-(2-nitro-1H-imidazol-1-yl)propanamido)propanamide(NI-Y-A) were synthesized and radioiodinated with 131I.All the radioiodinated compounds are obtained in >95% yield determined by HPLC and stable at room temperature for 24 h in vitro.The paper electrophoresis results indicate that the compounds formed are different in charge,NI-Y-M,NI-Y,and NI-Y-A are neutral,negative and positive,respectively.The biodistribution results in mice bearing S180 tumor demonstrate that all of the NI-Y-M,NI-Y and NI-Y-A accumulate in tumor fast and slowly clear from it.The uptakes in tumor are higher than those in muscle,heart,brain and spleen.The tumor-to-tissue ratios increase along with time.At 4 h post injection,the uptake ratios of tumor-to-muscle and tumor-to-blood indicate that among them the positively charged NI-Y-A is the best hypoxia agent.
Keywords:hypoxia imaging agent  2-nitroimidazole  131I radioiodination  charge  biodistribution
本文献已被 CNKI 等数据库收录!
点击此处可从《核化学与放射化学》浏览原始摘要信息
点击此处可从《核化学与放射化学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号